Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5207252
Max Phase: Preclinical
Molecular Formula: C37H63N15O6
Molecular Weight: 814.01
Associated Items:
ID: ALA5207252
Max Phase: Preclinical
Molecular Formula: C37H63N15O6
Molecular Weight: 814.01
Associated Items:
Canonical SMILES: N=C(N)NCCC[C@@H]1NC(=O)CCCC(=O)NCCCC[C@@H](C(=O)N[C@@H](CCCCN)C(=O)NCc2ccc(C(=N)N)cc2)NC(=O)[C@H](CCCNC(=N)N)NC1=O
Standard InChI: InChI=1S/C37H63N15O6/c38-18-3-1-8-25(32(55)48-22-23-14-16-24(17-15-23)31(39)40)50-34(57)27-9-2-4-19-45-29(53)12-5-13-30(54)49-26(10-6-20-46-36(41)42)33(56)52-28(35(58)51-27)11-7-21-47-37(43)44/h14-17,25-28H,1-13,18-22,38H2,(H3,39,40)(H,45,53)(H,48,55)(H,49,54)(H,50,57)(H,51,58)(H,52,56)(H4,41,42,46)(H4,43,44,47)/t25-,26-,27-,28-/m0/s1
Standard InChI Key: NDNGXRZICCRJQM-LJWNLINESA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 814.01 | Molecular Weight (Monoisotopic): 813.5086 | AlogP: -2.35 | #Rotatable Bonds: 18 |
Polar Surface Area: 374.29 | Molecular Species: BASE | HBA: 10 | HBD: 15 |
#RO5 Violations: 2 | HBA (Lipinski): 21 | HBD (Lipinski): 19 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 10.78 | CX Basic pKa: 12.65 | CX LogP: -4.88 | CX LogD: -13.90 |
Aromatic Rings: 1 | Heavy Atoms: 58 | QED Weighted: 0.04 | Np Likeness Score: 0.18 |
1. Osman EEA, Rehemtulla A, Neamati N.. (2022) Why All the Fury over Furin?, 65 (4.0): [PMID:34340303] [10.1021/acs.jmedchem.1c00518] |
Source(1):